{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:08:20Z","timestamp":1707523700238},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,7]]},"DOI":"10.7759\/cureus.28883","type":"journal-article","created":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T13:57:17Z","timestamp":1662559037000},"source":"Crossref","is-referenced-by-count":1,"title":["A Young Adult With Essential Thrombocythemia Presenting as Myocardial Infarction"],"prefix":"10.7759","author":[{"given":"Nagapratap","family":"Ganta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ankita","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Smriti","family":"Kochhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kajal","family":"Ghodasara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandeep","family":"Pavuluri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pramil","family":"Cheriyath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1177\/2634853520978210","article-title":"The essential thrombocythemia in 2020: what we know and where we still have to dig deep","volume":"13","author":"Accurso V","year":"2020","unstructured":"Accurso V, Santoro M, Mancuso S, et al.. The essential thrombocythemia in 2020: what we know and where we still have to dig deep. Clin Med Insights Blood Disord. 2020, 13:2634853520978210. 10.1177\/2634853520978210","journal-title":"Clin Med Insights Blood Disord"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1816082","article-title":"Essential thrombocythemia","volume":"381","author":"Tefferi A","year":"2019","unstructured":"Tefferi A, Pardanani A. Essential thrombocythemia. N Engl J Med. 2019, 381:2135-44. 10.1056\/NEJMcp1816082","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)71142-9","article-title":"Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders","volume":"366","author":"Baxter EJ","year":"2005915","unstructured":"Baxter EJ, Scott LM, Campbell PJ, et al.. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet. 2005915, 366:1054-61. 10.1016\/S0140-6736(05)71142-9","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-017-0041-8","article-title":"Essential thrombocythemia treatment algorithm 2018","volume":"8","author":"Tefferi A","year":"2018","unstructured":"Tefferi A, Vannucchi AM, Barbui T. Essential thrombocythemia treatment algorithm 2018. Blood Cancer J. 2018, 8:2. 10.1038\/s41408-017-0041-8","journal-title":"Blood Cancer J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1990.8.3.556","article-title":"Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia","volume":"8","author":"Cortelazzo S","year":"1990","unstructured":"Cortelazzo S, Viero P, Finazzi G, D'Emilio A, Rodeghiero F, Barbui T. Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia. J Clin Oncol. 1990, 8:556-62. 10.1200\/JCO.1990.8.3.556","journal-title":"J Clin Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830410405","article-title":"Essential thrombocythemia in pregnancy: platelet count and pregnancy outcome","volume":"41","author":"Chow EY","year":"1992","unstructured":"Chow EY, Haley LP, Vickars LM. Essential thrombocythemia in pregnancy: platelet count and pregnancy outcome. Am J Hematol. 1992, 41:249-51. 10.1002\/ajh.2830410405","journal-title":"Am J Hematol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2796.1998.00314.x","article-title":"Acute coronary disease in essential thrombocythemia and polycythemia vera","volume":"244","author":"Rossi C","year":"1998","unstructured":"Rossi C, Randi ML, Zerbinati P, Rinaldi V, Girolami A. Acute coronary disease in essential thrombocythemia and polycythemia vera. J Intern Med. 1998, 244:49-53. 10.1046\/j.1365-2796.1998.00314.x","journal-title":"J Intern Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-02-339002","article-title":"Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients","volume":"117","author":"Carobbio A","year":"2011","unstructured":"Carobbio A, Thiele J, Passamonti F, et al.. Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients. Blood. 2011, 117:5857-9. 10.1182\/blood-2011-02-339002","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-017-0035-6","article-title":"Risk factors for arterial versus venous thrombosis in polycythemia vera: a single center experience in 587 patients","volume":"7","author":"Cerquozzi S","year":"2017","unstructured":"Cerquozzi S, Barraco D, Lasho T, et al.. Risk factors for arterial versus venous thrombosis in polycythemia vera: a single center experience in 587 patients. Blood Cancer J. 2017, 7:662. 10.1038\/s41408-017-0035-6","journal-title":"Blood Cancer J"},{"key":"ref10","article-title":"Diagnosis and clinical manifestations of essential thrombocythemia","author":"Tefferi A","year":"2022","unstructured":"Tefferi A. Diagnosis and clinical manifestations of essential thrombocythemia. UpToDate. Post TW (ed): UpToDate, Waltham, MA; 2022."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.14744\/AnatolJCardiol.2015.6125","article-title":"Myocardial infarction as a thrombotic complication of essential thrombocythemia and polycythemia vera","volume":"16","author":"P\u00f3sfai \u00c9","year":"2016","unstructured":"P\u00f3sfai \u00c9, Marton I, Borb\u00e9nyi Z, Nemes A. Myocardial infarction as a thrombotic complication of essential thrombocythemia and polycythemia vera. Anatol J Cardiol. 2016, 16:397-402. 10.14744\/AnatolJCardiol.2015.6125","journal-title":"Anatol J Cardiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.12053","article-title":"Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments","volume":"93","author":"De Stefano V","year":"2008","unstructured":"De Stefano V, Za T, Rossi E, et al.. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments. Haematologica. 2008, 93:372-80. 10.3324\/haematol.12053","journal-title":"Haematologica"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/109920-a-young-adult-with-essential-thrombocythemia-presenting-as-myocardial-infarction","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:41:20Z","timestamp":1707507680000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/109920-a-young-adult-with-essential-thrombocythemia-presenting-as-myocardial-infarction"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,7]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.28883","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9,7]]}}}